Table 3.
Parameters | Frequency (%) n = 32 |
---|---|
Tumour stages | |
II | 4 (12.5) |
III | 25 (78.1) |
IV | 3 (9.4) |
Tumour grades | |
G1 | 1 (3.1) |
G2 | 12 (37.5) |
G3 | 18 (56.3) |
G4 | 1 (3.1) |
Molecular subtype | |
Luminal A | 6 (18.8) |
Luminal B | 10 (31.3) |
HER-2-enriched | 7 (21.8) |
Triple negative | 9 (28.1) |
Histopathological classification | |
Invasive carcinoma | 29 (90.6) |
Unknown | 3 (9.4) |
Location of cancer | |
Left breast | 18 (56.2) |
Right breast | 14 (43.8) |
n = breast cancer patients, HER-2-enriched = human epidermal growth factor receptor-2.